SANOFI VACCINES US INC. - THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE A/ASTRAKHAN/3212/2020 (H5N8)-LIKE INFLUENZA VIRUS SEEDS WILL BE PART OF THE US NATIONAL PRE-PANDEMIC VACCINE STOCKPILE.
Key Details
Description
THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE A/ASTRAKHAN/3212/2020 (H5N8)-LIKE INFLUENZA VIRUS SEEDS WILL BE PART OF THE US NATIONAL PRE-PANDEMIC VACCINE STOCKPILE.
Context & Analysis
On Dec 17, 2025, Department of Health and Human Services obligated $2,060,369 to SANOFI VACCINES US INC. for the purpose of this requirement is to provide a/astrakhan/3212/2020 (h5n8)-like influenza virus seeds will be part of the us national pre-pandemic vaccine stockpile.. The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition. Performance is located in SWIFTWATER, PA. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541714 — related awards are listed below.
Contractor Information
Similar Awards
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ALLUCENT GOVERNMENT SERVICES (US) LLC
$370.1M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.
$330.2M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
TECHNICAL RESOURCES INTERNATIONAL, INC.
$317.1M
ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION
PARATEK PHARMACEUTICALS, INC
$265.3M
ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA
GENENTECH INC
$243.7M
Stay Updated
Get notified about new opportunities matching your interests.